The global market for inhalation-based devices, used to manage asthma and chronic obstructive pulmonary disease (COPD), is expected to grow at a compound annual growth rate (CAGR) of 3%, reaching $12bn by 2023, and is driven by a greater prevalence of the disease and the aging population, according to a new analyst report "Drug Delivery: Inhalation Devices," from Informa's Meddevicetracker. Also see "Market Snapshot: Ventilators & Pulmonary Function Assessment Products Market Sees Moderate Growth" - Medtech Insight, 30 October, 2018.
According to Datamonitor Healthcare, in 2018, there were 111.6 million people living with asthma and COPD worldwide, with COPD accounting for 54% of the total cases. Over the next two...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?